Search Within

Carol A Aghajanian

Formats
  1. Journal Article (325)
  2. Meeting Abstract (284)
  3. Review (3)
  4. Book Section (1)
  5. Correspondence (1)
  6. Editorial (1)
Groups
  1. Department of Medicine (615)
  2. GDMT, Medicine (615)
  3. Gynecologic Medicine Service (615)
  4. Gynecology Disease Management Team (615)
  5. Solid Tumor Oncology Division (615)
  6. Surgery (229)

More Groups

People
  1. Nadeem Abu-Rustum (126)
  2. Paul Sabbatini (125)
  3. Alexia Iasonos (116)
  4. David Spriggs (105)
  5. Roisin O'Cearbhaill (99)
  6. Martee Hensley (94)

More People

Years
  1. 2025 (24)
  2. 2024 (38)
  3. 2023 (42)
  4. 2022 (45)
  5. 2021 (35)
  6. 2020 (61)

More Years

Publications
  1. Gynecologic Oncology (200)
  2. Journal of Clinical Oncology (150)
  3. International Journal of Gynecological Cancer (57)
  4. Clinical Cancer Research (30)
  5. Annals of Oncology (28)
  6. Cancer (15)

More Publications

Publishers
  1. Elsevier B.V. (204)
  2. American Society of Clinical Oncology (156)
  3. Lippincott Williams & Wilkins (59)
  4. American Association for Cancer Research (54)
  5. Oxford University Press (30)
  6. Elsevier Inc. (21)

More Publishers

Results (615)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Whole-genome sequencing-based characterization of endometrial serous carcinoma
    Journal Article

    Andres, S.; Brown, D. N.; da Cruz Paula, A.; Aghajanian, C.; Abu-Rustum, N. R.; Ellenson, L. H.; Weigelt, B.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Germline landscape of high grade serous ovarian cancer across age groups: Is age just a number?
    Journal Article

    Sia, T. Y.; Moufarrij, S.; Milani, J.; Kane, S.; Zhou, Q.; Fong, C.; Khurram, A.; Kemel, Y. M.; Sheehan, M.; Latham, A.; more...
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save
  • Therapeutic targeting of mismatch repair-deficient cancers
    Review

    Johannet, P.; Rousseau, B.; Aghajanian, C.; Foote, M. B.; Diaz, L. A. Jr
    Nature Reviews Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Ongoing genome doubling shapes evolvability and immunity in ovarian cancer
    Journal Article

    McPherson, A.; Vázquez-García, I.; Myers, M. A.; Al-Rawi, D. H.; Zatzman, M.; Weiner, A. C.; Freeman, S.; Mohibullah, N.; Satas, G.; Williams, M. J.; more...
    Nature (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of avutometinib ± defactinib in recurrent low-grade serous ovarian cancer: Primary analysis of ENGOT-OV60/GOG-3052/RAMP 201
    Journal Article

    Banerjee, S. N.; Van Nieuwenhuysen, E.; Aghajanian, C.; D'Hondt, V.; Monk, B. J.; Clamp, A.; Prendergast, E.; Oaknin, A.; Ring, K.; Colombo, N.; more...
    Journal of Clinical Oncology (2025)

    Fulltext@MSK | Save
  • Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial
    Journal Article

    Ledermann, J. A.; Oza, A. M.; Lorusso, D.; Aghajanian, C.; Oaknin, A.; Dean, A.; Colombo, N.; Weberpals, J. I.; Clamp, A. R.; Scambia, G.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • Veliparib concomitant with first-line chemotherapy and as maintenance therapy in ovarian cancer: Final overall survival and disease-related symptoms results
    Journal Article

    Coleman, R. L.; Fleming, G. F.; Brady, M. F.; Swisher, E. M.; Steffensen, K. D.; Friedlander, M.; Okamoto, A.; Moore, K. N.; Leath, C. A. 3rd; Cella, D.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • A phase II study of fulvestrant plus abemaciclib in hormone receptor–positive advanced or recurrent endometrial cancer
    Journal Article

    Green, A. K.; Zhou, Q.; Iasonos, A.; Zammarrelli, W. A. 3rd; Weigelt, B.; Ellenson, L. H.; Chhetri-Long, R.; Shah, P.; Loh, J.; Hom, V.; more...
    Clinical Cancer Research (2025)

    Fulltext@MSK | Save
  • Pembrolizumab plus chemotherapy in advanced or recurrent endometrial cancer: Overall survival and exploratory analyses of the NRG GY018 phase 3 randomized trial
    Journal Article

    Eskander, R. N.; Sill, M. W.; Beffa, L.; Moore, R. G.; Hope, J. M.; Musa, F. B.; Mannel, R. S.; Shahin, M. S.; Cantuaria, G. H.; Girda, E.; more...
    Nature Medicine (2025)

    Fulltext@MSK | Save
  • Prognostic significance of estrogen receptor expression and estrogen signaling in endometrial carcinomas of no specific molecular profile: A comprehensive molecular and pathologic analysis
    Journal Article

    Lam, C.; Zhou, Q.; Aghajanian, C.; Abu-Rustum, N. R.; Mueller, J. J.; Ellenson, L. H.; Green, A. K.; Weigelt, B.; Jungbluth, A. A.; Momeni-Boroujeni, A.
    Gynecologic Oncology (2025)

    Fulltext@MSK | Save